Locations:

Tag: elaine husni

June 30, 2020/Rheumatology & Immunology/Research

Intravenous Golimumab for Psoriatic Arthritis: GO-VIBRANT at 1 Year

Sustained efficacy and safety

February 27, 2020/Rheumatology & Immunology

PROMIS Measures Are Associated with Disease Activity in Psoriatic Arthritis

Patients with minimal disease activity report better physical and mental health as well as less fatigue

October 17, 2019/Basic & Translational Science

Targeting Tumor Necrosis Factor Pathways in Psoriatic Diseases: The Next Step

Husni lab recently funded by NIH-NIAMS

January 2, 2018/Rheumatology & Immunology/Research

Targeting Biomarkers of Nitric Oxide and Endothelial Dysfunction in RA and PsA

Translational human plasma studies

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

16-rhe-2743-husni-hero-image-650×450-pxl

December 21, 2016/Rheumatology & Immunology/Research

PRECISION Results = Precisely Tailored Arthritis Treatment

Ten-year data show celecoxib noninferior to NSAIDs

September 23, 2015/Rheumatology & Immunology/Rheumatic Diseases

In Psoriatic Diseases, HDL-Associated Antioxidant Enzymes Show Promise as a Cardiac Risk Tool

First study of paraoxonase-1 activity levels in psoriatic diseases

October 10, 2014/Heart, Vascular and Thoracic

Assessing Cardiovascular Disease Risk in Psoriatic Arthritis Patients

Carotid Ultrasound Study Shows Need for Better Prevention

BackPage 1 of 1Next